Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
LY487379 is a positive allosteric modulator of metabotropic glutamate receptor 2 (mGluR2).1 It is selective for mGluR2 over mGluR3 in cells expressing recombinant mGluR2 or mGluR3 (IC50s = 1.7 and >10 µM, respectively). LY487379 reduces MK-801-induced superoxide dismutase (SOD) activity in mouse frontal cortex and hippocampal homogenates.2 In vivo, LY487379 (30 mg/kg) increases cognitive flexibility in the attentional set-shifting task and decreases impulsive behavior in the differential reinforcement of low rate 72s (DRL72) schedule of food reinforcement in rats.3 It also decreases the severity of dyskinesia and psychotic-like behaviors induced by L-DOPA (Item No. 13248) in a 6-MPTP-lesioned marmoset model of Parkinson's disease when administered at a dose of 1 or 10 mg/kg.4
WARNING This product is not for human or veterinary use.
1. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2. Mol. Pharmacol. 64(4), 798-810 (2003).
2. The impact of muscarinic and mGlu receptors modulators on MK-
3. Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-
4. Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-